These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 22105456

  • 1. Transition of severe diffuse mesangial hypercellularity to minimal change disease in a child with steroid-resistant nephrotic syndrome.
    Fujinaga S, Watanabe T, Endo A, Hirano D, Ohtomo Y, Shimizu T, Kaneko K.
    Clin Nephrol; 2011 Dec; 76(6):504-6. PubMed ID: 22105456
    [No Abstract] [Full Text] [Related]

  • 2. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K, Ito H, Anzai M, Matsumura C, Kurayama H.
    J Nephrol; 2013 Dec; 26(2):306-14. PubMed ID: 22641570
    [Abstract] [Full Text] [Related]

  • 3. A study of glomerular minimal lesion and minimal mesangial proliferation with or without nephrotic syndrome; pathologic, immunopathologic and clinical correlations.
    Choi IJ, Jeong HJ, Kim PK, Lee JS, Kim KS, Lee HY, Chung SH, Kim DS.
    Yonsei Med J; 1986 Dec; 27(1):17-24. PubMed ID: 3300054
    [No Abstract] [Full Text] [Related]

  • 4. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
    Swartz SJ, Eldin KW, Hicks MJ, Feig DI.
    Pediatr Nephrol; 2009 Jun; 24(6):1187-92. PubMed ID: 19219463
    [Abstract] [Full Text] [Related]

  • 5. Primary nephrotic syndrome in Iran: clinicopathological study of 310 cases.
    Bodaghi E, Vazirian S, Madani A, Shmsa AM, Afzali HM, Elmi F.
    Int J Pediatr Nephrol; 1986 Jun; 7(3):127-30. PubMed ID: 3804576
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
    Maruyama M, Toyoda M, Umezono T, Miyauchi M, Yamamoto N, Kimura M, Honma M, Nishina M, Endoh M, Sakai H, Suzuki D.
    Nihon Jinzo Gakkai Shi; 2006 Jun; 48(1):14-21. PubMed ID: 16480062
    [Abstract] [Full Text] [Related]

  • 7. Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: a separate entity? Observation of two cases.
    Barbiano di Belgiojoso G, Mazzucco G, Casanova S, Radaelli L, Monga G, Minetti L.
    Am J Nephrol; 1986 Jun; 6(2):141-5. PubMed ID: 3518456
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M.
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [Abstract] [Full Text] [Related]

  • 9. Pathology of nephrotic syndrome with minimal or minor glomerular changes.
    Grishman E, Churg J.
    Perspect Nephrol Hypertens; 1973 Mar; 1 Pt 1():165-81. PubMed ID: 4536421
    [No Abstract] [Full Text] [Related]

  • 10. Nephrotic syndrome associated with diffuse mesangial hypercellularity: is it a heterogeneous disease entity?
    Joh K, Matsuyama N, Kanetsuna Y, Usui N, Hattori M, Yumura W, Aizawa S.
    Am J Nephrol; 1998 Mar; 18(3):214-20. PubMed ID: 9627037
    [Abstract] [Full Text] [Related]

  • 11. Steroid-dependent nephrotic syndrome with minimal glomerular changes and mesangial IgA deposits.
    Gallego N, Gonzalo A, Mampaso F, Ortuño J.
    Child Nephrol Urol; 1998 Mar; 9(1-2):98-100. PubMed ID: 3251631
    [Abstract] [Full Text] [Related]

  • 12. [Histologic transition in patients with minimal-change nephrotic syndrome to mesangial IgM nephropathy].
    Claros González I, Baños Gallardo M, Forascepi Roza R, Argüelles Toraño M.
    Rev Clin Esp; 1986 Dec; 179(9):476-7. PubMed ID: 3809684
    [No Abstract] [Full Text] [Related]

  • 13. Lipoid nephrosis: a reassessment.
    Jao W, Lewy P, Norris SH, Pollak VE, Pirani CL.
    Perspect Nephrol Hypertens; 1973 Dec; 1 Pt 1():183-98. PubMed ID: 4620918
    [No Abstract] [Full Text] [Related]

  • 14. Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellularity.
    Alexopoulos E, Papagianni A, Stangou M, Pantzaki A, Papadimitriou M.
    Nephrol Dial Transplant; 2000 Jul; 15(7):981-7. PubMed ID: 10862635
    [Abstract] [Full Text] [Related]

  • 15. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome.
    Ji-Yun Y, Melvin T, Sibley R, Michael AF.
    Kidney Int; 1984 Jan; 25(1):100-6. PubMed ID: 6727121
    [Abstract] [Full Text] [Related]

  • 16. [Glomerular kidney diseases that are associated with a large clinical proteinuria and/or nephrotic syndrome].
    Danilewicz M.
    Pol J Pathol; 2011 Jun; 62(2 Suppl 1):s32-40. PubMed ID: 23120829
    [No Abstract] [Full Text] [Related]

  • 17. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F, Liebl R, Riegger GA, Krämer BK.
    Nephrol Dial Transplant; 1997 Nov; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract] [Full Text] [Related]

  • 18. [Lipoid nephrosis in childhood].
    Niaudet P.
    Rev Prat; 2003 Nov 30; 53(18):2027-32. PubMed ID: 15008217
    [Abstract] [Full Text] [Related]

  • 19. IgM nephropathy: morphological study related to clinical findings.
    Kopolovic J, Shvil Y, Pomeranz A, Ron N, Rubinger D, Oren R.
    Am J Nephrol; 1987 Nov 30; 7(4):275-80. PubMed ID: 3318460
    [Abstract] [Full Text] [Related]

  • 20. Mesangial IgA deposits with steroid responsive nephrotic syndrome: probable minimal lesion nephrosis.
    Sinnassamy P, O'Regan S.
    Am J Kidney Dis; 1985 May 30; 5(5):267-9. PubMed ID: 4003395
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.